Literature DB >> 29535405

Empirically derived dietary habits are associated with irritable bowel syndrome.

Fatemeh Zaribaf1,2, Ammar Hassanzadeh Keshteli3,4, Ahmad Esmaillzadeh5,6,7,8,9, Parvane Saneei1,2,10, Awat Feizi3,11,12, Hamed Daghaghzadeh3, Christine Feinle-Bisset13, Peyman Adibi3.   

Abstract

BACKGROUND/
OBJECTIVES: The associations between empirically derived dietary habits and irritable bowel syndrome (IBS) have not been investigated. This study aimed to assess the relationship between empirically derived dietary habits and IBS in a large population of Iranian adults. SUBJECTS/
METHODS: In a cross-sectional study, dietary habits of 4763 adults were assessed in three domains, "meal pattern", "eating rate" and "intra-meal fluid intake". We used latent class analysis to identify classes of dietary habits. IBS was defined based on ROME III criteria.
RESULTS: IBS was prevalent in 20.3% (n = 966) of the study population. Two distinct classes of meal patterns: "regular" and "irregular", three classes of eating rates: "moderate", "moderate-to-slow" and "moderate-to-fast" and two classes of fluid ingestion with meals: "moderate" and "heavy intra-meal drinking" were identified. After adjustment for confounders, "heavy intra-meal fluid intake" was protectively associated with IBS (OR = 0.79; 95% CI:0.64-0.96). When potential confounders were considered, "meal pattern" and "eating rate" were not significantly associated with IBS in the whole population. After adjustment for confounders, women with "irregular meal pattern" had a 30% greater risk of having IBS, compared with those with "regular meal pattern" (OR = 1.30; 95% CI:1.02-1.67). Overweight participants with "fast eating rate" were 70% more likely to have IBS, compared to those with "moderate eating rate" (OR = 1.70; 95% CI:1.13-2.55). "Irregular meal pattern" was related to frequency and severity of abdominal pain.
CONCLUSIONS: We found a significant association between heavy intra-meal fluid intake" and IBS. More large-scale prospective studies are needed to affirm this association.

Entities:  

Mesh:

Year:  2018        PMID: 29535405     DOI: 10.1038/s41430-018-0109-y

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  7 in total

Review 1.  Irritable bowel syndrome in midlife women: a narrative review.

Authors:  Pei-Lin Yang; Margaret M Heitkemper; Kendra J Kamp
Journal:  Womens Midlife Health       Date:  2021-05-31

2.  The relationship between meal regularity with Irritable Bowel Syndrome (IBS) in adults.

Authors:  Narges Ghorbani Bavani; Zahra Hajhashemy; Parvane Saneei; Ammar Hassanzadeh Keshteli; Ahmad Esmaillzadeh; Peyman Adibi
Journal:  Eur J Clin Nutr       Date:  2022-03-10       Impact factor: 4.884

3.  A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients.

Authors:  Clara Nilholm; Bodil Roth; Bodil Ohlsson
Journal:  Nutrients       Date:  2019-07-20       Impact factor: 5.717

4.  Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients.

Authors:  Clara Nilholm; Ewa Larsson; Bodil Roth; Rita Gustafsson; Bodil Ohlsson
Journal:  Nutrients       Date:  2019-06-05       Impact factor: 5.717

Review 5.  Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.

Authors:  Justyna Paulina Wielgosz-Grochowska; Nicole Domanski; Małgorzata Ewa Drywień
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

6.  Association of Diet, Body Mass Index, and Lifestyle on the Gastrointestinal Health Risk in a Sample of Adults.

Authors:  Reyna Sámano; Fernanda Esparza-Juárez; Gabriela Chico-Barba; Erika González-Medina; Bernarda Sánchez-Jiménez; María Hernández-Trejo
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

7.  Water consumption and prevalence of irritable bowel syndrome among adults.

Authors:  Asma Salari-Moghaddam; Ammar Hassanzadeh Keshteli; Ahmad Esmaillzadeh; Peyman Adibi
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.